Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Ertumaxomab [USAN:INN]
RN: 509077-99-0
UNII: L5L45YGP1O

Note

  • Trifunctional anti-HER2 x anti-CD3 antibody for treatment of metastatic breast cancer; in Phase I trial (5/2006).

Molecular Formula

  • Unspecified
 
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Ertumaxomab
  • Ertumaxomab [USAN:INN]

Synonyms

  • Ertumaxomab
  • Immunoglobulin G2a, anti-(human neu (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), bidisulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
  • UNII-L5L45YGP1O

Registry Numbers

CAS Registry Number

  • 509077-99-0

FDA UNII

  • L5L45YGP1O

System Generated Number

  • 0509077990